Author

KENNETH L. MAREK

Institute for Neurodegenerative DisordersORCID 0000-0002-4197-5627Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genetic & Genomic Medicine· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:benchmarking· 2 Approach:statistical model· 2 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:machine learning (classical)· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Andrew SingletoniD· 3 shared Lana M. ChahineiD· 2 shared Tatiana ForoudiD· 2 shared Alastair John NoyceiD· 1 shared Ali DaneshmandiD· 1 shared Anant DaduiD· 1 shared Andrew D. SiderowfiD· 1 shared Arthur W. TogaiD· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioinformatics

Andrew SingletonORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Bioinformaticsnpj Parkinson s DiseasePeer-reviewedDec 16, 2022

Identification and prediction of Parkinson's disease subtypes and progression using machine learning in two cohorts.

Anant Dadu, Vipul K. Satone, Rachneet Kaur…·Faraz Faghri

This study uses machine learning to identify Parkinson's disease subtypes and predict progression in two cohorts, finding three subtypes with distinct progression rates and high prediction accuracy.

115 citationstop 1%

humanmachine learning (classical)

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintMar 21, 2022

Dystonia-Parkinsonism Gene Variants in Individuals with Parkinsonism and Brain Scans without Evidence for Dopaminergic Deficit (SWEDD)

Kelly Nicole Holohan Nudelman, Yajing Yan Yan Xiong, Lola P. Cook…·The Parkinson’s Progression Markers Initiative

This study identifies pathogenic variants in dystonia-parkinsonism genes in 12.5% of SWEDD cases in the PPMI cohort, highlighting the importance of genetic testing in this patient group.

1 citation

humanwhole-genome sequencing

𝕏 PostBluesky

NeuroscienceMovement DisordersPeer-reviewedAug 15, 2020

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

Brit Mollenhauer, Mohammed Dakna, Niels Kruse…·Danielle L. Graham

This paper validates serum neurofilament light chain (NfL) as a biomarker for Parkinson's disease progression, showing increased levels in PD patients compared to healthy controls and a longitudinal increase correlating with clinical severity.

197 citationstop 1%

humanstatistical model

𝕏 PostBluesky